Validation of multiple linked administrative datasets to identify people with dementia
- 1 September 2025
- journal article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 107 (2) , 671-681
Abstract
Background: Accurately measuring dementia prevalence and incidence (including Alzheimer's disease) is important for service planning and chronic condition management. Linked administrative data present an accessible and inexpensive method to estimate dementia prevalence and incidence. Objective: To examine the accuracy of identifying people with dementia in linked administrative data through comparison with adjudicated cases of dementia from a community-based clinical trial. Methods: We created a comprehensive linked administrative dataset containing people with dementia in Australia and used it to develop algorithms that identified people with dementia. These algorithms were tested against adjudicated cases of dementia (both confirmed and not confirmed) in the ASPirin in Reducing Events in the Elderly (ASPREE) clinical trial (Number: ISRCTN83772183, Registration date: 14/07/2005) to help determine optimal sensitivity and specificity. Results: The algorithm that provided the highest sensitivity and positive predictive value estimates on balance without excluding ASPREE trial participants with suspected (but not confirmed) dementia was having at least one record for dementia in a minimum of two sources or two records with dementia in one source based on truncating the timeframe of randomization in the ASPREE trial to one year from the date that the first participant was randomized. This algorithm produced a sensitivity of 70.7%, specificity of 98.2%, positive predictive value of 72.6% and negative predictive value of 98.1%. Conclusions: Linked administrative data can identify people with dementia with moderate accuracy. This is promising but requires enhancement before it can be used for estimating dementia prevalence and incidence. Clinical trial name and URL: ASPirin in Reducing Events in the Elderly; ISRCTN - ISRCTN83772183: ASPirin in Reducing Events in the Elderly ( https://www.isrctn.com/ISRCTN83772183 )Keywords
Funding Information
- Australian National Health and Medical Research Council Grant Boosting Dementia Grants Project (1171319)
This publication has 20 references indexed in Scilit:
- Measuring dementia incidence within a cohort of 267,153 older Australians using routinely collected linked administrative dataScientific Reports, 2020
- Effect of Aspirin on Disability-free Survival in the Healthy ElderlyNew England Journal of Medicine, 2018
- Effect of Aspirin on All-Cause Mortality in the Healthy ElderlyNew England Journal of Medicine, 2018
- Identifying dementia cases with routinely collected health data: A systematic reviewAlzheimer's & Dementia, 2018
- Changing non-participation in epidemiological studies of older people: evidence from the Cognitive Function and Ageing Study I and IIAge and Ageing, 2015
- The prevalence and causes of younger onset dementia in Eastern Sydney, AustraliaInternational Psychogeriatrics, 2014
- Validity of dementia and Alzheimer's disease diagnoses in Finnish national registersAlzheimer's & Dementia, 2013
- Trends in Asthma Prevalence and Incidence in Ontario, Canada, 1996-2005: A Population StudyAmerican Journal of Epidemiology, 2010
- Participation Rates in Epidemiologic StudiesAnnals of Epidemiology, 2007
- Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995–2005: a population-based studyThe Lancet, 2007